Takeda Pharmaceutical Company Limited
USD15.98
+0.07 (+0.44%)
CEO
Christophe Weber
IPO Date
2010-01-05
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Country
JP
Open
$15.97
Prev. Close
$15.91
Day Low
$15.87
Day High
$16.05
52W Low
$12.99
52W High
$18.90
Market Cap
$50.49B
Volume
3.54M
| 64.6 |
| 31 Mar 2024 | FY | 54.5% | 3.4% | 2.0% | 1.0% | 0.75 | 1.11 | 45.2 |
| 31 Mar 2023 | FY | 57.1% | 7.9% | 5.0% | 2.3% | 0.77 | 0.97 | 21.3 |
| 31 Mar 2022 | FY | 57.3% | 6.4% | 4.0% | 1.7% | 0.85 | 1.21 | 23.8 |
| 31 Mar 2021 | FY | 56.2% | 11.8% | 7.3% | 2.9% | 0.98 | 1.53 | 16.6 |
| 31 Mar 2020 | FY | 54.4% | 1.3% | 0.9% | 0.3% | 1.16 | 1.13 | 116.4 |
| 31 Mar 2019 | FY | 60.8% | 6.4% | 2.6% | 1.0% | 1.18 | 1.21 | 32.5 |
| 31 Mar 2018 | FY | 64.9% | 10.6% | 9.4% | 4.6% | 0.52 | 1.46 | 21.7 |
| 31 Mar 2017 | FY | 58.8% | 6.6% | 6.1% | 2.6% | 0.63 | 0.92 | 35.5 |
| 18.4 |
| 30 Sept 2025 | Q2 | 65.8% | -1.1% | -0.2% | -0.1% | 0.65 | 1.36 | -144.2 |
| 30 Jun 2025 | Q1 | 53.3% | 11.2% | 1.8% | 0.9% | 0.66 | 1.16 | 13.9 |
| 31 Mar 2025 | Q4 | 51.5% | -9.8% | -1.5% | -0.7% | 0.73 | 1.01 | -16.9 |
| 31 Dec 2024 | Q3 | 51.8% | 2.1% | 0.3% | 0.2% | 0.65 | 1.31 | 69.7 |
| 30 Sept 2024 | Q2 | 54.4% | 7.8% | 1.3% | 0.6% | 0.73 | 1.28 | 17.6 |
| 30 Jun 2024 | Q1 | 54.5% | 7.9% | 1.2% | 0.6% | 0.70 | 1.26 | 17.3 |
| 31 Mar 2024 | Q4 | 50.9% | -0.3% | -0.0% | -0.0% | 0.75 | 1.11 | -540.6 |
| 31 Dec 2023 | Q3 | 53.8% | 9.5% | 1.6% | 0.7% | 0.69 | 1.06 | 15.0 |